BET-IN-16 (Comp I), a bromodomain and extra-terminal (BET) inhibitor, demonstrates anticancer activity by impeding the growth of prostate cancer cells. It exhibits potent inhibitory effects with half-maximal inhibitory concentration (IC50) values of 0.043 µM for LNCaP cells and 0.034 µM for 22Rv1 cells [1].
Molekulargewicht:
515.56
CAS Nummer:
[2089390-09-8]
Formel:
C31H25N5O3
Target-Kategorie:
Epigenetic Reader Domain
T78989
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten